000			01978 a2200529 4500
005			20250515225705.0
264		0	_c20100806
008			201008s 0 0 eng d
022			_a1474-4465
024	7		_a10.1016/S1474-4422(10)70132-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aRavnborg, Mads
245	0	0	_aMethylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. _h[electronic resource]
260			_bThe Lancet. Neurology _cJul 2010
300			_a672-80 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aDisability Evaluation
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon beta-1a
650	0	4	_aInterferon-beta _xtherapeutic use
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLongitudinal Studies
650	0	4	_aMale
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy
650	0	4	_aNeuroprotective Agents _xtherapeutic use
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aSørensen, Per Soelberg
700	1		_aAndersson, Magnus
700	1		_aCelius, Elisabeth G
700	1		_aJongen, Peter J
700	1		_aElovaara, Irina
700	1		_aBartholomé, Emmanuel
700	1		_aConstantinescu, Cris S
700	1		_aBeer, Karsten
700	1		_aGarde, Ellen
700	1		_aSperling, Bjørn
773	0		_tThe Lancet. Neurology _gvol. 9 _gno. 7 _gp. 672-80
856	4	0	_uhttps://doi.org/10.1016/S1474-4422(10)70132-0 _zAvailable from publisher's website
999			_c19892498 _d19892498